Event Videos

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052191/ Hepatitis
Klin Padiatr. 2020 Mar 19. doi: 10.1055/a-1108-1553. [Epub ahead of print]

Hepatitis-associated Aplastic Anaemia in Children.

Böske AK1, Sander A2, Sykora KW2, Ullrich B1, Pfister ED1.

Abstract

in English, German

BACKGROUND:
Children with idiopathic acute liver failure (IALF) are at a high risk of developing life-threatening bone marrow failure (BMF). The aim of the study was to describe the development, therapy and prognosis of this hepatitis-associated aplastic anaemia (HAAA) in comparison to isolated acquired aplastic anaemia.

RESULTS:

Published on: 
Mar-2020

https://www.ncbi.nlm.nih.gov/pubmed/32189246 Hepatopulmonary syndrome
Indian J Gastroenterol. 2020 Mar 18. doi: 10.1007/s12664-020-01015-0. [Epub ahead of print]

Natural history, risk factors, and outcome of hepatopulmonary syndrome in pediatric liver diseases.
Pandey S1, Sood V1, Khanna R1, Lal BB1, Sood AK2, Kabra SK3, Alam S4.

Abstract

BACKGROUND:
Limited pediatric literature is available regarding hepatopulmonary syndrome (HPS) especially in subjects with biliary atresia (BA) despite its proven prognostic significance. Thus, we aimed to study the natural history, risk factors, and outcome of HPS in BA and other chronic liver disease (CLD) subjects.

METHODS:

Published on: 
Mar-2020

https://www.ncbi.nlm.nih.gov/pubmed/32189930 Hepatitis B

J Clin Exp Hepatol. 2020 Mar-Apr;10(2):150-154. doi: 10.1016/j.jceh.2019.04.002. Epub 2019 Apr 18.

Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children.

Wani MA1, Sodhi JS2, Zargar SA2, Yatoo GN2, Shah A2, Aziz SA3, Geelani S4, Haq I5, Gulzar GM2, Khan M2, Haq I6.

Abstract

OBJECTIVE:
Hepatitis B infection is common in patients with cancer, and prompt treatment is necessary; otherwise, it can result in life-threatening complications. The objective of this study was to assess the long-term safety and efficacy of entecavir in immunocompromised children with hepatitis B.

METHODS:

Published on: 
Mar-2020

https://www.ncbi.nlm.nih.gov/pubmed/32166118 Glycogen storage disease
Clin Exp Hepatol. 2020 Feb;6(1):9-12. doi: 10.5114/ceh.2020.93050. Epub 2020 Feb 17.
Prevalence and clinical profile of glycogen storage diseases in children from Western India.
Shah I1, Tolani D1, Shetty NS1, Karkare V1.
Author information

Abstract

AIM OF THE STUDY:
To determine the prevalence and clinical profile of glycogen storage diseases (GSD) in children in western India.

MATERIAL AND METHODS:
This retrospective analysis was conducted over a period of 7 years from 2006 to 2012. All children diagnosed with GSD on liver biopsy were included in the study. Their clinical history, examination, biochemical profile and outcome were noted.

RESULTS:

Published on: 
Mar-2020

https://www.ncbi.nlm.nih.gov/pubmed/32205770 Hepatitis C

J Pediatr Gastroenterol Nutr. 2020 Mar 20. doi: 10.1097/MPG.0000000000002710. [Epub ahead of print]
Comparison of Recommendations for Treatment of Chronic Hepatitis C Virus Infection in Children and Adolescents: A Position Paper of the Global Federation of International Societies of International Societies of Pediatric Gastroenterology, Hepatology and Nutrition (FISPGHAN).
Indolfi G1, Fischler B2, Gonzalez-Peralta RP3, Ciocca M4, Porta G5, Neelam M6, Guindi ME7, Kelly D8, Ni YH9, Sibal A10, Leung DH11, Chang MH12; Hepatitis Expert Team of the Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition (FISPGHAN).

Abstract

OBJECTIVE:

Published on: 
Mar-2020

https://www.ncbi.nlm.nih.gov/pubmed/32171275 NAFLD

BMC Pediatr. 2020 Mar 14;20(1):121. doi: 10.1186/s12887-020-02022-y.
Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017.
Kim MJ1, Lee KJ2.
Author information

Abstract

BACKGROUND:

Published on: 
Mar-2020

https://www.ncbi.nlm.nih.gov/pubmed/32206627 PFIC

Pediatr Gastroenterol Hepatol Nutr. 2020 Mar;23(2):146-153. doi: 10.5223/pghn.2020.23.2.146. Epub 2020 Mar 4.

Liver Involvement in Children with Alpha-1 Antitrypsin Deficiency: A Multicenter Study.

Cakir M1, Sag E1, Islek A2, Baran M3, Tumgor G4, Aydogdu S5.

Abstract

PURPOSE:
Alpha-1 antitrypsin deficiency (A1ATD) in one of the most common genetic causes of liver disease in children. We aimed to analyze the clinical characteristics and outcomes of patients with A1ATD.

METHODS:
This study included patients with A1ATD from five pediatric hepatology units. Demographics, clinical findings, genetics, and outcome of the patients were recorded (n=25).

RESULTS:

Published on: 
Mar-2020

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: